Ignite Creation Date:
2024-05-05 @ 11:59 AM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00209131
Status:
TERMINATED
Last Update Posted:
2013-10-28
First Post:
2005-09-14
Brief Title:
Efficacy of Flomax to Improve Stone Passage Following Shock Wave Lithotripsy
Sponsor:
Emory University
Organization:
Emory University
Study Overview
Official Title:
Efficacy of Flomax to Improve Stone Passage Following Shock Wave Lithotripsy
Status:
TERMINATED
Status Verified Date:
2013-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Due to frequent turnover of research coordinators and thus poor study accrual
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The majority of kidney stones are treated with shock wave lithotripsy SWL We are examining if the medication Flomax will result in improved stone passage rates following SWL
Detailed Description:
Placebo blinded study examining the effects of Flomax on stone passage rates following SWL
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None